Numerous researches have also indicated that TREM1 inhibitors could confer protective effect in pathological conditions with excessive immune responses, including stroke, myocardial infarction, inflammatory bowel diseases, atherosclerosis, fibrosis and cancer (9, 22, 25, 28, 36, 37, 44–46). Here, TREM1 is linked to inflammatory bowel disease.